Terminally ill cancer patients continue to receive aggressive treatment at end of life

Key points
- A new report, presented at the annual meeting of the American Society of Clinical Oncology in Atlanta, confirms and expands on similar findings involving cancer care in the early 1990s, and the new data confirm the validity of the methods used to reach these conclusions.
- "We have essentially found the same trends up to 1999 now," said Craig Earle, M.D., a Dana-Farber specialist in outcomes research.
- "The use of hospice definitely increased steadily over this time period," he said.
- Earle said that the National Institutes of Health-sponsored study would continue to collect data for two more years, and that he and his colleagues are looking at whether the same pattern is occurring in younger patients who aren't eligible for Medicare.
The increasing use of chemotherapy and intensive hospital treatment for cancer patients in their last two weeks of life continued at least into the late 1990s despite the growth of the hospice movement that emphasizes comforting personal bonds and controlling pain and discomfort, say researchers at the Dana-Farber Cancer Institute in Boston.
A new report, presented at the annual meeting of the American Society of Clinical Oncology in Atlanta, confirms and expands on similar findings involving cancer care in the early 1990s, and the new data confirm the validity of the methods used to reach these conclusions.
"We have essentially found the same trends up to 1999 now," said Craig Earle, M.D., a Dana-Farber specialist in outcomes research. The study covered some 215,488 Medicare-eligible patients aged 65 and older in 77 Health Care Service Areas across the country, and, while there were significant variations in use of aggressive treatment, the overall trend has continued, said Earle.
"The use of hospice definitely increased steadily over this time period," he said. "But an increasing number of patients were admitted to hospice in just the last three days of life, so the hospices were not being used for symptom relief and building relationships," he said.
Earle said that the National Institutes of Health-sponsored study would continue to collect data for two more years, and that he and his colleagues are looking at whether the same pattern is occurring in younger patients who aren't eligible for Medicare.
The study's validity is strengthened, he said, by the most recent data showing that the differing levels of intensive treatment in different regions held up over several years.
More and more people are receiving appropriate hospice care, but too often it appears that doctors "are treating patients up to the end and then saying, go to the hospice," Earle said. This interpretation was based on data showing that an increasing number of patients who were seen in emergency rooms or admitted to intensive care units during the last month of life. At the same time, however, there was a drop in the number of cancer patients dying in acute-care hospitals, and that more terminal patients were using hospice facilities.
"As oncologists," said Earle, "we need to make sure that we view hospice care for what it is, an important part of the care continuum that focuses on keeping patients comfortable and free of pain."
http://www.dfci.harvard.edu
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsGenomic testing can help identify patients at heightened risk for esophageal cancer
Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is…
9 June 2015
NewsNew study finds that proton therapy has fewer side effects in esophageal cancer patients
New research by scientists at the University of Maryland School of Medicine has found that esophageal cancer patients treated with proton therapy experienced significantly less toxic side effects than patients treated…
23 May 2015
NewsMoffitt researchers work to determine why some prostate cancer patients experience more hot flashes
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after…






